1240483-24-2 Usage
General Description
The chemical "(3aR,4R,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-4-((R,E)-3-((tert-butyldimethylsilyl)oxy)-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one" is a complex compound containing a cyclopentane ring and multiple functional groups. It has tert-butyldimethylsilyl groups and a trifluoromethyl group, which are commonly used as protective or activating groups in organic synthesis. The compound also contains an unsaturated chain and a cyclic ketone, which are important functional groups in organic chemistry. (3aR,4R,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-4-((R,E)-3-((tert-butyldimethylsilyl)oxy)-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one may have applications in pharmaceuticals, agrochemicals, or materials science, and its synthesis likely involves multiple steps and careful control of reaction conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1240483-24-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,0,4,8 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1240483-24:
(9*1)+(8*2)+(7*4)+(6*0)+(5*4)+(4*8)+(3*3)+(2*2)+(1*4)=122
122 % 10 = 2
So 1240483-24-2 is a valid CAS Registry Number.
1240483-24-2Relevant articles and documents
Secondary compounds in the catalytic hydrogenation of enone and allylic alcohol prostaglandin intermediates: Isolation, characterization, and X-ray crystallography
Tǎnase, Constantin I.,Cocu, Florea,Drǎghici, Constantin,Hanganu, Anamaria,Pintilie, Lucia,Maganu, Maria,Munteanu, Cristian V. A.,Shova, Sergiu
, p. 7582 - 7599 (2019/05/27)
The discovery of the intraocular pressure reduction of 13,14-hydrogenated prostaglandins, among which Latanoprost is the most used drug in glaucoma treatment, has stimulated researchers to improve the synthesis of prostaglandins and their structural analo
PROCESS FOR THE PREPARATION OF F-SERIES PROSTAGLANDINS
-
, (2011/05/05)
A process for the synthesis and purification of F-series prostaglandin compounds and synthetic intermediates used to prepare them. The synthetic intermediates are solid and may be purified by precipitation and therefore may form the representative F-series prostaglandin compounds such as latanoprost, bimatoprost, fluprostenol, cloprostenol, and substituted analogs therefrom in highly pure forms.
